Palacios Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
836
+15
+2% +$15.3K 0.59% 32
2026
Q1
$767K Buy
821
+124
+18% +$126K 0.48% 31
2025
Q4
$749K Sell
697
-426
-38% -$407K 0.57% 30
2025
Q3
$857K Buy
1,123
+423
+60% +$315K 0.56% 31
2025
Q2
$546K Sell
700
-10,026
-93% -$7.79M 0.45% 40
2025
Q1
$351K Buy
10,726
+10,059
+1,508% +$8.37M 0.26% 43
2024
Q4
$500K Buy
+667
New +$552K 0.54% 36

Other funds holding LLY

Palacios Wealth Management's LLY Position: Q2 2026 in Review

Palacios Wealth Management increased its Eli Lilly (LLY) stake by 1.8% in Q2 2026, buying an estimated $15.3K and bringing the position to 836 shares worth $1M. The position accounts for 0.59% of the portfolio, ranked #32.

Palacios Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Palacios Wealth Management held 836 shares of Eli Lilly worth $1M as of Q2 2026.
  • Palacios Wealth Management bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.59% of Palacios Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Palacios Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Palacios Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.